CLINICAL_TRIALS
trial_result
· 2014-06-30
Clinical Trial Update: TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients [Phase 2]
Summary
Phase 2 trial update of TALL-104 with Gleevec for chronic myeloid leukemia; the study was terminated and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myelogenous Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2014-06-30